SCHEMBL29879061

SCHEMBL29879061

Cc1cc(CNc2nc(Cl)ncc2N)ccc1-c1nc(C(F)(F)F)cn1C

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 1/20 0.38
▸ PDE2A O00408 1/20 0.37
▸ USP1 O94782 17/20 0.34
▸ WDR48 Q8TAF3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27031470 1.00 CSF1R (0.38) CSF1RPDE2AUSP1WDR48
SCHEMBL29878992 0.92 USP1 (0.39) CSF1RPDE2AUSP1
SCHEMBL27031623 0.92 USP1 (0.39) CSF1RPDE2AUSP1
SCHEMBL27031506 0.90 CSF1R (0.36) CSF1RPDE2AUSP1
SCHEMBL29878443 0.90 CSF1R (0.36) CSF1RPDE2AUSP1
SCHEMBL27097114 0.88 USP1 (0.37) CSF1RPDE2AUSP1
SCHEMBL18865875 0.86 USP1 (0.42) PDE2AUSP1
SCHEMBL27031674 0.83 USP1 (0.38) PDE2AUSP1
SCHEMBL29878980 0.83 USP1 (0.38) PDE2AUSP1
SCHEMBL25430986 0.81 USP1 (0.38) PDE2AUSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308566-A1 PURINE DERIVATIVES AS ANTICANCER AGENTS Tango Therapeutics, Inc. (US) 2024-01-24 — — EP disclosed
CN-117425656-A Purine derivatives as anticancer agents 探戈医药股份有限公司 2024-01-19 — — CN disclosed
WO-2022197892-A1 PURINE DERIVATIVES AS ANTICANCER AGENTS TANGO THERAPEUTICS, INC. (US) 2022-09-22 — — WO disclosed
Send feedback